A study to assess the effects of a broad-spectrum immune modulatory therapy on mortality and morbidity in patients with chronic heart failure: The ACCLAIM trial rationale and design Academic Article uri icon

Overview

MeSH Major

  • Heart Failure
  • Immunologic Factors
  • Randomized Controlled Trials as Topic

abstract

  • If the ACCLAIM trial confirms earlier results, this approach represents a novel nonpharmacological treatment for HF that targets a pathogenic mechanism contributing to progression of this syndrome not addressed by current therapies.

publication date

  • April 2007

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC2649187

PubMed ID

  • 17440642

Additional Document Info

start page

  • 369

end page

  • 76

volume

  • 23

number

  • 5